ASND Ascendis Pharma ADRs

Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$93.23  -1.87 (-1.97%)
As of 06/28/2022 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Denmark
Country of incorporation:  
IPO date:  01/28/2015
Outstanding shares:  56,962,558
Average volume:  387,018
Market cap:   $5,188,719,408
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BV9G6B8
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.85
PS ratio:   355.02
Return on equity:   -66.33%
Net income %:   -3,219.70%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy